Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Ablation of Ventricular Arrhythmias Arising From the Pulmonary Artery.

JACC. Case reports

Nademanee K.
PMID: 34825201
JACC Case Rep. 2021 Nov 17;3(16):1743-1745. doi: 10.1016/j.jaccas.2021.09.007. eCollection 2021 Nov 17.

No abstract available.

Cite
Nademanee K. Ablation of Ventricular Arrhythmias Arising From the Pulmonary Artery. JACC Case Rep. 2021;3(16):1743-1745doi: 10.1016/j.jaccas.2021.09.007.
Nademanee, K. (2021). Ablation of Ventricular Arrhythmias Arising From the Pulmonary Artery. JACC. Case reports, 3(16), 1743-1745. https://doi.org/10.1016/j.jaccas.2021.09.007
Nademanee, Koonlawee. "Ablation of Ventricular Arrhythmias Arising From the Pulmonary Artery." JACC. Case reports vol. 3,16 (2021): 1743-1745. doi: https://doi.org/10.1016/j.jaccas.2021.09.007
Nademanee K. Ablation of Ventricular Arrhythmias Arising From the Pulmonary Artery. JACC Case Rep. 2021 Nov 17;3(16):1743-1745. doi: 10.1016/j.jaccas.2021.09.007. eCollection 2021 Nov 17. PMID: 34825201; PMCID: PMC8603044.
Copy Download .nbib Format: NLM
Clinical Characteristics of .

Circulation. Genomic and precision medicine

Chimparlee N, Prechawat S, Khongphatthanayothin A, Mauleekoonphairoj J, Lekchuensakul S, Wongcharoen W, Makarawate P, Sahasatas D, Krittayaphong R, Amnueypol M, Anannab A, Ngarmukos T, Vardhanabhuti S, Sutjaporn B, Wandee P, Veerakul G, Bezzina CR, Poovorawan Y, Nademanee K.
PMID: 34092119
Circ Genom Precis Med. 2021 Jun;14(3):e003229. doi: 10.1161/CIRCGEN.120.003229. Epub 2021 Jun 07.

No abstract available.

Cite
Chimparlee N, Prechawat S, Khongphatthanayothin A, et al. Clinical Characteristics of . Circ Genom Precis Med. 2021;14(3):e003229doi: 10.1161/CIRCGEN.120.003229.
Chimparlee, N., Prechawat, S., Khongphatthanayothin, A., Mauleekoonphairoj, J., Lekchuensakul, S., Wongcharoen, W., Makarawate, P., Sahasatas, D., Krittayaphong, R., Amnueypol, M., Anannab, A., Ngarmukos, T., Vardhanabhuti, S., Sutjaporn, B., Wandee, P., Veerakul, G., Bezzina, C. R., Poovorawan, Y., & Nademanee, K. (2021). Clinical Characteristics of . Circulation. Genomic and precision medicine, 14(3), e003229. https://doi.org/10.1161/CIRCGEN.120.003229
Chimparlee, Nitinan, et al. "Clinical Characteristics of ." Circulation. Genomic and precision medicine vol. 14,3 (2021): e003229. doi: https://doi.org/10.1161/CIRCGEN.120.003229
Chimparlee N, Prechawat S, Khongphatthanayothin A, Mauleekoonphairoj J, Lekchuensakul S, Wongcharoen W, Makarawate P, Sahasatas D, Krittayaphong R, Amnueypol M, Anannab A, Ngarmukos T, Vardhanabhuti S, Sutjaporn B, Wandee P, Veerakul G, Bezzina CR, Poovorawan Y, Nademanee K. Clinical Characteristics of . Circ Genom Precis Med. 2021 Jun;14(3):e003229. doi: 10.1161/CIRCGEN.120.003229. Epub 2021 Jun 07. PMID: 34092119.
Copy Download .nbib Format: NLM
Multisite conduction block in the epicardial substrate of Brugada syndrome.

Heart rhythm

Haïssaguerre M, Nademanee K, Sacher F, Cheniti G, Hocini M, Surget E, Dubois R, Vigmond E, Bernus O.
PMID: 34737095
Heart Rhythm. 2021 Nov 01; doi: 10.1016/j.hrthm.2021.10.030. Epub 2021 Nov 01.

BACKGROUND: The Brugada pattern manifests as a spontaneous variability of the electrocardiographic marker, suggesting a variability of the underlying electrical substrate.OBJECTIVE: The purpose of this study was to investigate the response of the epicardial substrate of Brugada syndrome (BrS)...

Cite
Haïssaguerre M, Nademanee K, Sacher F, et al. Multisite conduction block in the epicardial substrate of Brugada syndrome. Heart Rhythm. 2021;doi: 10.1016/j.hrthm.2021.10.030.
Haïssaguerre, M., Nademanee, K., Sacher, F., Cheniti, G., Hocini, M., Surget, E., Dubois, R., Vigmond, E., & Bernus, O. (2021). Multisite conduction block in the epicardial substrate of Brugada syndrome. Heart rhythm, . https://doi.org/10.1016/j.hrthm.2021.10.030
Haïssaguerre, Michel, et al. "Multisite conduction block in the epicardial substrate of Brugada syndrome." Heart rhythm vol. (2021). doi: https://doi.org/10.1016/j.hrthm.2021.10.030
Haïssaguerre M, Nademanee K, Sacher F, Cheniti G, Hocini M, Surget E, Dubois R, Vigmond E, Bernus O. Multisite conduction block in the epicardial substrate of Brugada syndrome. Heart Rhythm. 2021 Nov 01; doi: 10.1016/j.hrthm.2021.10.030. Epub 2021 Nov 01. PMID: 34737095.
Copy Download .nbib Format: NLM
Double-hit Signature with .

Clinical cancer research : an official journal of the American Association for Cancer Research

Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD.
PMID: 33414134
Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 07.

PURPOSE: We performed detailed genomic analysis on 87 cases of EXPERIMENTAL DESIGN: The cases were extensively characterized by combining the results of IHC, cell-of-origin gene expression profiling (GEP; NanoString), double-hit GEP (DLBCL90), FISH cytogenetic analysis for double/triple-hit lymphoma, copy-number...

Cite
Song JY, Perry AM, Herrera AF, et al. Double-hit Signature with . Clin Cancer Res. 2021;27(6):1671-1680doi: 10.1158/1078-0432.CCR-20-2378.
Song, J. Y., Perry, A. M., Herrera, A. F., Chen, L., Skrabek, P., Nasr, M. R., Ottesen, R. A., Nikowitz, J., Bedell, V., Murata-Collins, J., Li, Y., McCarthy, C., Pillai, R., Wang, J., Wu, X., Zain, J., Popplewell, L., Kwak, L. W., Nademanee, A. P., Niland, J. C., Scott, D. W., Gong, Q., Chan, W. C., & Weisenburger, D. D. (2021). Double-hit Signature with . Clinical cancer research : an official journal of the American Association for Cancer Research, 27(6), 1671-1680. https://doi.org/10.1158/1078-0432.CCR-20-2378
Song, Joo Y, et al. "Double-hit Signature with ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,6 (2021): 1671-1680. doi: https://doi.org/10.1158/1078-0432.CCR-20-2378
Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD. Double-hit Signature with . Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 07. PMID: 33414134.
Copy Download .nbib Format: NLM
Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome.

Heart rhythm

Nademanee K, Veerakul G, Nogami A, Lou Q, Hocini M, Coronel R, Behr ER, Wilde A, Boukens BJ, Haissaguerre M.
PMID: 34742919
Heart Rhythm. 2021 Nov 04; doi: 10.1016/j.hrthm.2021.10.031. Epub 2021 Nov 04.

BACKGROUND: The mechanisms by which sodium channel blockade and high-rate pacing modify electrogram (EGM) substrates of Brugada syndrome (BrS) have not been elucidated.OBJECTIVE: The purpose of this study was to determine the effect of ajmaline and high pacing rate...

Cite
Nademanee K, Veerakul G, Nogami A, et al. Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome. Heart Rhythm. 2021;doi: 10.1016/j.hrthm.2021.10.031.
Nademanee, K., Veerakul, G., Nogami, A., Lou, Q., Hocini, M., Coronel, R., Behr, E. R., Wilde, A., Boukens, B. J., & Haissaguerre, M. (2021). Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome. Heart rhythm, . https://doi.org/10.1016/j.hrthm.2021.10.031
Nademanee, Koonlawee, et al. "Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome." Heart rhythm vol. (2021). doi: https://doi.org/10.1016/j.hrthm.2021.10.031
Nademanee K, Veerakul G, Nogami A, Lou Q, Hocini M, Coronel R, Behr ER, Wilde A, Boukens BJ, Haissaguerre M. Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome. Heart Rhythm. 2021 Nov 04; doi: 10.1016/j.hrthm.2021.10.031. Epub 2021 Nov 04. PMID: 34742919.
Copy Download .nbib Format: NLM
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Journal of arrhythmia

Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER, Chugh SS, Cornel MC, Gardner K, Ingles J, James CA, Juang JJ, Kääb S, Kaufman ES, Krahn AD, Lubitz SA, MacLeod H, Morillo CA, Nademanee K, Probst V, Saarel EV, Sacilotto L, Semsarian C, Sheppard MN, Shimizu W, Skinner JR, Tfelt-Hansen J, Wang DW.
PMID: 34141003
J Arrhythm. 2021 Apr 08;37(3):481-534. doi: 10.1002/joa3.12449. eCollection 2021 Jun.

This international multidisciplinary document intends to provide clinicians with evidence-based practical patient-centered recommendations for evaluating patients and decedents with (aborted) sudden cardiac arrest and their families. The document includes a framework for the investigation of the family allowing steps...

Cite
Stiles MK, Wilde AAM, Abrams DJ, et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. J Arrhythm. 2021;37(3):481-534doi: 10.1002/joa3.12449.
Stiles, M. K., Wilde, A. A. M., Abrams, D. J., Ackerman, M. J., Albert, C. M., Behr, E. R., Chugh, S. S., Cornel, M. C., Gardner, K., Ingles, J., James, C. A., Juang, J. J., Kääb, S., Kaufman, E. S., Krahn, A. D., Lubitz, S. A., MacLeod, H., Morillo, C. A., Nademanee, K., Probst, V., Saarel, E. V., Sacilotto, L., Semsarian, C., Sheppard, M. N., Shimizu, W., Skinner, J. R., Tfelt-Hansen, J., & Wang, D. W. (2021). 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Journal of arrhythmia, 37(3), 481-534. https://doi.org/10.1002/joa3.12449
Stiles, Martin K, et al. "2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families." Journal of arrhythmia vol. 37,3 (2021): 481-534. doi: https://doi.org/10.1002/joa3.12449
Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER, Chugh SS, Cornel MC, Gardner K, Ingles J, James CA, Juang JJ, Kääb S, Kaufman ES, Krahn AD, Lubitz SA, MacLeod H, Morillo CA, Nademanee K, Probst V, Saarel EV, Sacilotto L, Semsarian C, Sheppard MN, Shimizu W, Skinner JR, Tfelt-Hansen J, Wang DW. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. J Arrhythm. 2021 Apr 08;37(3):481-534. doi: 10.1002/joa3.12449. eCollection 2021 Jun. PMID: 34141003; PMCID: PMC8207384.
Copy Download .nbib Format: NLM
Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans.

Journal of cardiovascular pharmacology and therapeutics

Nademanee K, Noll HE, Feld GK.
PMID: 10684394
J Cardiovasc Pharmacol Ther. 1996 Jan;1(1):9-16. doi: 10.1177/107424849600100103.

BACKGROUND: The effects of sotalol on refractoriness in human ventricular and atrial muscles have been well established, but the drug's effect on the electrical properties of the His-Purkinje system in humans is not known, especially whether sotalol's effect is...

Cite
Nademanee K, Noll HE, Feld GK. Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans. J Cardiovasc Pharmacol Ther. 1996;1(1):9-16doi: 10.1177/107424849600100103.
Nademanee, K., Noll, H. E., & Feld, G. K. (1996). Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans. Journal of cardiovascular pharmacology and therapeutics, 1(1), 9-16. https://doi.org/10.1177/107424849600100103
Nademanee, et al. "Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans." Journal of cardiovascular pharmacology and therapeutics vol. 1,1 (1996): 9-16. doi: https://doi.org/10.1177/107424849600100103
Nademanee K, Noll HE, Feld GK. Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans. J Cardiovasc Pharmacol Ther. 1996 Jan;1(1):9-16. doi: 10.1177/107424849600100103. PMID: 10684394.
Copy Download .nbib Format: NLM
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.

Blood advances

Herrera AF, Palmer J, Adhikarla V, Yamauchi D, Poku EK, Bading J, Yazaki P, Dandapani S, Mei M, Chen R, Cao T, Karras N, McTague P, Nademanee A, Popplewell L, Sahebi F, Shively JE, Simpson J, Smith DL, Song J, Spielberger R, Tsai NC, Thomas SH, Forman SJ, Colcher D, Wu AM, Wong J, Smith E.
PMID: 34638132
Blood Adv. 2021 Dec 14;5(23):5300-5311. doi: 10.1182/bloodadvances.2021004981.

High-risk relapsed or refractory (R/R) classical Hodgkin lymphoma (HL) is associated with poor outcomes after conventional salvage therapy and autologous hematopoietic cell transplantation (AHCT). Post-AHCT consolidation with brentuximab vedotin (BV) improves progression-free survival (PFS), but with increasing use of...

Cite
Herrera AF, Palmer J, Adhikarla V, et al. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood Adv. 2021;5(23):5300-5311doi: 10.1182/bloodadvances.2021004981.
Herrera, A. F., Palmer, J., Adhikarla, V., Yamauchi, D., Poku, E. K., Bading, J., Yazaki, P., Dandapani, S., Mei, M., Chen, R., Cao, T., Karras, N., McTague, P., Nademanee, A., Popplewell, L., Sahebi, F., Shively, J. E., Simpson, J., Smith, D. L., Song, J., Spielberger, R., Tsai, N. C., Thomas, S. H., Forman, S. J., Colcher, D., Wu, A. M., Wong, J., & Smith, E. (2021). Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood advances, 5(23), 5300-5311. https://doi.org/10.1182/bloodadvances.2021004981
Herrera, Alex F, et al. "Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma." Blood advances vol. 5,23 (2021): 5300-5311. doi: https://doi.org/10.1182/bloodadvances.2021004981
Herrera AF, Palmer J, Adhikarla V, Yamauchi D, Poku EK, Bading J, Yazaki P, Dandapani S, Mei M, Chen R, Cao T, Karras N, McTague P, Nademanee A, Popplewell L, Sahebi F, Shively JE, Simpson J, Smith DL, Song J, Spielberger R, Tsai NC, Thomas SH, Forman SJ, Colcher D, Wu AM, Wong J, Smith E. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood Adv. 2021 Dec 14;5(23):5300-5311. doi: 10.1182/bloodadvances.2021004981. PMID: 34638132.
Copy Download .nbib Format: NLM
Radiofrequency ablation in Brugada syndrome.

Heart rhythm

Nademanee K.
PMID: 34600611
Heart Rhythm. 2021 Oct;18(10):1805-1806. doi: 10.1016/j.hrthm.2021.08.005.

No abstract available.

Cite
Nademanee K. Radiofrequency ablation in Brugada syndrome. Heart Rhythm. 2021;18(10):1805-1806doi: 10.1016/j.hrthm.2021.08.005.
Nademanee, K. (2021). Radiofrequency ablation in Brugada syndrome. Heart rhythm, 18(10), 1805-1806. https://doi.org/10.1016/j.hrthm.2021.08.005
Nademanee, Koonlawee. "Radiofrequency ablation in Brugada syndrome." Heart rhythm vol. 18,10 (2021): 1805-1806. doi: https://doi.org/10.1016/j.hrthm.2021.08.005
Nademanee K. Radiofrequency ablation in Brugada syndrome. Heart Rhythm. 2021 Oct;18(10):1805-1806. doi: 10.1016/j.hrthm.2021.08.005. PMID: 34600611.
Copy Download .nbib Format: NLM
Double-hit Signature with .

Clinical cancer research : an official journal of the American Association for Cancer Research

Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD.
PMID: 33414134
Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 07.

PURPOSE: We performed detailed genomic analysis on 87 cases of EXPERIMENTAL DESIGN: The cases were extensively characterized by combining the results of IHC, cell-of-origin gene expression profiling (GEP; NanoString), double-hit GEP (DLBCL90), FISH cytogenetic analysis for double/triple-hit lymphoma, copy-number...

Cite
Song JY, Perry AM, Herrera AF, et al. Double-hit Signature with . Clin Cancer Res. 2021;27(6):1671-1680doi: 10.1158/1078-0432.CCR-20-2378.
Song, J. Y., Perry, A. M., Herrera, A. F., Chen, L., Skrabek, P., Nasr, M. R., Ottesen, R. A., Nikowitz, J., Bedell, V., Murata-Collins, J., Li, Y., McCarthy, C., Pillai, R., Wang, J., Wu, X., Zain, J., Popplewell, L., Kwak, L. W., Nademanee, A. P., Niland, J. C., Scott, D. W., Gong, Q., Chan, W. C., & Weisenburger, D. D. (2021). Double-hit Signature with . Clinical cancer research : an official journal of the American Association for Cancer Research, 27(6), 1671-1680. https://doi.org/10.1158/1078-0432.CCR-20-2378
Song, Joo Y, et al. "Double-hit Signature with ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,6 (2021): 1671-1680. doi: https://doi.org/10.1158/1078-0432.CCR-20-2378
Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD. Double-hit Signature with . Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 07. PMID: 33414134.
Copy Download .nbib Format: NLM
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.

Blood advances

Herrera AF, Palmer J, Adhikarla V, Yamauchi D, Poku EK, Bading J, Yazaki P, Dandapani S, Mei M, Chen R, Cao T, Karras N, McTague P, Nademanee A, Popplewell L, Sahebi F, Shively JE, Simpson J, Smith DL, Song J, Spielberger R, Tsai NC, Thomas SH, Forman SJ, Colcher D, Wu AM, Wong J, Smith E.
PMID: 34638132
Blood Adv. 2021 Dec 14;5(23):5300-5311. doi: 10.1182/bloodadvances.2021004981.

High-risk relapsed or refractory (R/R) classical Hodgkin lymphoma (HL) is associated with poor outcomes after conventional salvage therapy and autologous hematopoietic cell transplantation (AHCT). Post-AHCT consolidation with brentuximab vedotin (BV) improves progression-free survival (PFS), but with increasing use of...

Cite
Herrera AF, Palmer J, Adhikarla V, et al. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood Adv. 2021;5(23):5300-5311doi: 10.1182/bloodadvances.2021004981.
Herrera, A. F., Palmer, J., Adhikarla, V., Yamauchi, D., Poku, E. K., Bading, J., Yazaki, P., Dandapani, S., Mei, M., Chen, R., Cao, T., Karras, N., McTague, P., Nademanee, A., Popplewell, L., Sahebi, F., Shively, J. E., Simpson, J., Smith, D. L., Song, J., Spielberger, R., Tsai, N. C., Thomas, S. H., Forman, S. J., Colcher, D., Wu, A. M., Wong, J., & Smith, E. (2021). Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood advances, 5(23), 5300-5311. https://doi.org/10.1182/bloodadvances.2021004981
Herrera, Alex F, et al. "Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma." Blood advances vol. 5,23 (2021): 5300-5311. doi: https://doi.org/10.1182/bloodadvances.2021004981
Herrera AF, Palmer J, Adhikarla V, Yamauchi D, Poku EK, Bading J, Yazaki P, Dandapani S, Mei M, Chen R, Cao T, Karras N, McTague P, Nademanee A, Popplewell L, Sahebi F, Shively JE, Simpson J, Smith DL, Song J, Spielberger R, Tsai NC, Thomas SH, Forman SJ, Colcher D, Wu AM, Wong J, Smith E. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood Adv. 2021 Dec 14;5(23):5300-5311. doi: 10.1182/bloodadvances.2021004981. PMID: 34638132.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries